Continuous Tableting Lines
At GEA we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product life-cycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Our solution for continuous tableting lines is ConsiGma®, a 6 sigma-inspired manufacturing platform, incorporating different technologies to produce oral solid dosage forms in a continuous, cost-efficient way:
- by collecting more information during R&D phase, in a short time with less product
- by excluding risky, time- and product consuming scale-up exercises
- by introducing online measurement and closed loop control targeting real-time release (6 sigma production)
- by incorporating flexible batch size (JIT production), reducing inventory
- by reducing the energy cost per tablet, reducing environmental impact.
Products
Mostrar 4 de 8
ConsiGma® Compact Feeder (CF) Test Rig
The ConsiGma® CF20 test rig is a standalone module that allows you to characterize the feeding behavior of your products during the early stages of R&D.
ConsiGma® Conductor
An indispensable part of the ConsiGma portfolio, the Conductor control system architecture ensures smooth operation and communication between the different elements of a pharmaceutical continuous manufacturing line
ConsiGma® Direct Compression with Linear Blending (DC-LB) Lines
A highly integrated solution for continuous linear blending and direct compression, the ConsiGma® DC-LB lines offer all the advantages of continuous manufacturing: supply chain agility, small footprint, controlled blending and compression and improved quality.
ConsiGma® Dosing and Blending (DB) Modules
Designed to achieve optimal blending results, the ConsiGma® DB modules facilitate the testing of dosing and blending operations and can be integrated with any continuous up- or downstream process.
Downloads
GEA Insights
GEA reports profitable growth for 2025 and expects accelerated revenue growth
GEA’s past fiscal year was one of significant growth and further profitability gains. In particular, the technology group substantially increased order intake, with all divisions contributing here. GEA also made progress in all Mission 30 strategic growth areas. In addition, GEA met key interim targets under its climate plan ahead of schedule. Major milestones in fiscal year 2025 were admission to the DAX index, the award of one of the largest contracts in the company’s history, and streamlining of the corporate structure.
SmartParc reescribe las reglas de la producción alimentaria
Gracias a un nuevo centro de fabricación SmartParc, los procesadores de alimentación del Reino Unido están reduciendo sus costes de funcionamiento y sus emisiones. Con la tecnología de calefacción y refrigeración de GEA en su núcleo, este modelo de producción colaborativa demuestra cómo la innovación está acelerando las ambiciones de cero emisiones netas de la industria.
El patio de recreo de la ciencia alimentaria
"Elaborar huevos es como elaborar cerveza". Es el tipo de comparación que te hace sonreír, y te das cuenta: De repente, algo complejo parece sencillo. Con esta película personal, ambientada en el corazón agrícola de EE.UU., exploramos la fermentación de precisión y el trabajo real que supone convertir una idea en alimentos.
